Trial Profile
A non interventional study to evaluate the efficacy and tolerability of intravenous lacosamide in patients with Epilepsy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Mar 2017
Price :
$35
*
At a glance
- Drugs Lacosamide (Primary)
- Indications Epilepsy
- Focus Therapeutic Use
- 04 Mar 2017 New trial record